
American Cell Technology (ACT) provides a safe and trusted environment to store personal stem cells with the highest standards. As a leading US stem cell company, ACT is recognized for setting benchmarks in safety and reliability for stem cell banking in America, helping individuals and families preserve their cells for future regenerative needs. Whether storing stem cells from the birth of a new family member or banking your own adult stem cells from adipose or bone marrow, American Cell Technology utilizes proprietary technology, in a FDA registered, current good tissue practice (cGTP) facility to safely store your cells. This commitment to innovation positions ACT among the most advanced stem cell banking companies in the US, ensuring that every client benefits from a secure, science-backed process.
Doctors and scientists continue to advance this field. Your own cells, with your own DNA have limitless potential as regenerative medicine continues to evolve. Research into stem cells in the US is expanding rapidly, and companies like ACT are playing a vital role in supporting this progress by preserving high-quality, viable cells for future use. American Cell Technology grows potentially billions of your own cells in a sterile environment, cryopreserves (freezes in liquid nitrogen) those cells in the highest standards, making them available when requested in the future. By banking with ACT, individuals gain peace of mind knowing their stem cells are preserved in the US under precise conditions and ready to support new developments in regenerative medicine when needed.

Store your own cells, with your own DNA, only available for you – eliminating the risk of rejection of foreign DNA.

Join the ACT family through safely storing your youngest cells and having access to these cells throughout your life.
ACT works with top medical practitioners with varying specialties across the US that trusts ACT in banking their patients’ cells

ACT uses proprietary technology and the highest quality media when working with your cells.

Clinical Studies using stem cells for various treatments are currently being conducted and can be found on Clinicaltrials, where study sponsors submit information about their study to Clinicaltrials and is responsible for the safety, science, and accuracy of any study they list. These studies highlight the increasing importance of stem cells in America, where continuous innovation is shaping the next generation of regenerative therapies and research opportunities.
Clinicaltrials.gov is a website and online database of clinical research studies and their results, maintained by The National Library of Medicine (NLM). A broad range of public and private organizations around the world sponsor (oversee) and fund (pay the costs) studies listed in the Clinicaltrials.gov database. U.S. government agencies neither oversee nor fund all the studies listed on ClinicalTrials.gov. AMERICAN CELL TECHNOLOGY DOES NOT PROMOTE THE USE OF STEM CELLS FOR ANY SPECIFIC TREATMENT INDICATIONS. POTENTIAL TREATMENT USES SHOULD BE DISCUSSED BETWEEN THE PATIENT AND THEIR PHYSICIAN.
